(Q44535601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

S Savelev

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E Okello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N S L Perry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E K Perry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology, Biochemistry and Behavior

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

661-668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

Antibacterial properties of alafosfalin combined with cephalexin

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

A Method for Testing for Synergy with Any Number of Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

The expected effect of a combination of agents: the general solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Minor synergy and antagonism may be clinically important

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Composition of essential oils from turkish Salvia species

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Cholinesterase inhibitors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

The fractional inhibitory concentration (FIC) index as a measure of synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

A chemical and pharmacological investigation of Piper methysticum Forst

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Composition of the Essential Oils of Commercial Samples of Salvia officinalis L. andS. fruticosa Miller: A Comparison of Oils Obtained by Extraction and Steam Distillation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Inhibition of acetylcholinesterase activity by essential oil from Citrus paradisi

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Necropsy evidence of central cholinergic deficits in senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Changes in brain cholinesterases in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Essential oils from dalmatian sage (Salvia officinalis l.): variations among individuals, plant parts, seasons, and sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900125-4

7 January 2021

10.1016/S0091-3057(03)00125-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12895684%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference